Barclays Maintains an 'Overweight' on Nike (NKE); Q3 Preview: Raising FY on Continued Strength
Tweet
Share
E-mailGet Alerts NKE Hot Sheet
Price: $94.64 +0.66%
Rating Summary:
32 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
32 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Nike (NYSE: NKE) price target of $125.00.
Analyst, Robert S. Drbul, said, "We remain comfortable with our EPS estimate of $1.19, which is $0.03 above consensus. We expect Nike to deliver continued double digit revenue growth, as implied by the futures increase of +13.0% reported in 2Q12. We expect revenue to increase 14.2% to $5.80 billion."
"Given our expectation for strong futures, driven by ongoing product evolution, upcoming launches and significant athletic events, combined with our expectation for sequential gross margin improvement, we are raising our FY13 EPS to $5.80 from $5.75."
For an analyst ratings summary and ratings history on Nike click here. For more ratings news on Nike click here.
Shares of Nike closed at $109.45 yesterday.
Analyst, Robert S. Drbul, said, "We remain comfortable with our EPS estimate of $1.19, which is $0.03 above consensus. We expect Nike to deliver continued double digit revenue growth, as implied by the futures increase of +13.0% reported in 2Q12. We expect revenue to increase 14.2% to $5.80 billion."
"Given our expectation for strong futures, driven by ongoing product evolution, upcoming launches and significant athletic events, combined with our expectation for sequential gross margin improvement, we are raising our FY13 EPS to $5.80 from $5.75."
For an analyst ratings summary and ratings history on Nike click here. For more ratings news on Nike click here.
Shares of Nike closed at $109.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
- Boston Scientific (BSX) PT Raised to $83 at Stifel
- BofA Securities Starts GE Vernova (GEV) at Neutral, 'Multiyear turnaround amid positive demand backdrop'
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
